WeVote
Log In

Bill

Bill

SB 790

Opioid antagonists; dispensing and administration by person acting on behalf of an organization.

2025 Regular Session Introduced by Chris Head

Expands access to opioid antagonist distribution by authorizing organizational representatives, not just individual professionals, to dispense and administer naloxone for overdose emergencies.

Incorporated by Education and Health (SB1035-Pekarsky) (15-Y 0-N)
0
WeVote Research Nonpartisan
Bill Summary · SB 790

Legislative bill overview

SB 790 expands who can dispense and administer opioid antagonists (like naloxone/Narcan) by allowing designated representatives of organizations—not just individual pharmacists or trained persons—to distribute these life-saving drugs. The bill was incorporated into SB 1035 by the Education and Health Committee, suggesting its provisions were merged into broader legislation.

Why is this important

Opioid overdose deaths remain a significant public health crisis. By expanding access points for opioid antagonists through organizational representatives, the bill could increase availability in community settings, workplaces, and institutions where overdoses may occur. Faster access to naloxone can mean the difference between life and death in overdose emergencies.

Potential points of contention

  • Training and liability concerns: Organizations may face questions about whether representatives need formal training and who bears legal responsibility if administration causes harm or is performed incorrectly
  • Scope of "organizations": Unclear which types of entities (schools, nonprofits, businesses, government agencies) would be eligible to have representatives dispense antagonists, potentially creating equity issues
  • Regulatory oversight: The bill may lack clear guidelines on storage, record-keeping, and oversight mechanisms to ensure antagonists are used appropriately and tracked properly

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.